PENBRAYA

Pfizer Laboratories Div Pfizer Inc🇺🇸 United States

FDA Page

Effective Date: Mar 17, 2026
Approval ID: fd5652b6-5ae4-437e-a456-47deaf500794
Products: 1 registered
Version: 9

Regulatory Information

Labeling Type

VACCINE LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use PENBRAYA safely and effectively. See full prescribing information for PENBRAYA. PENBRAYA (Meningococcal Groups A, B, C, W, and Y Vaccine), suspension for intramuscular injectionInitial U.S. Approval: 2023

Quick Stats

Total Products1

Labelers2

Label Sections34

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.